HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-negative and anti-hepatitis B core antigen antibodies (anti-HBc) positive (past HBV infection) patients receiving immuno-chemotherapy for hematological malignancies. A higher rate of HBVr is associated...

Full description

Bibliographic Details
Main Authors:	Michele Clerico, Irene Dogliotti, Paola Ghione, Vittorio Ruggero Zilioli, Francesco Merli, Barbara Botto, Wael Al Essa, Marcella Battaglini, Daniele Grimaldi, Loretta Cervi, Simone Ragaini, Simone Ferrero, Veronica Peri, Gabriele De Luca, Alfredo Marzano, Federica Cavallo
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Journal of Personalized Medicine
Subjects:	hepatitis B virus (HBV) non-Hodgkin lymphoma (NHL) HBV reactivation (HBVr) rituximab lamivudine (LAM)
Online Access:	https://www.mdpi.com/2075-4426/12/2/285

Similar Items

Lamivudine for chronic hepatitis B: a brief review
by: Emilio Palumbo

Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis
by: Aoran Luo, et al.
Published: (2018-09-01)

Antiviral therapy against chronic hepatitis B in Brazil: high rates of lamivudine resistance mutations and correlation with HBV genotypes
by: Francisco Campello do Amaral Mello, et al.
Published: (2012-05-01)

The efficacy of lamivudine in the treatment of reactivation of chronic hepatitis B virus infection in patients on immunosuppressive therapy
by: Delić Dragan, et al.
Published: (2011-01-01)

Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B
by: Mangano Carmelo, et al.
Published: (2011-01-01)

Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
by: Lazarević Ivana, et al.
Published: (2014-01-01)

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
by: João Marcello de Araujo-Neto, et al.
Published: (2022-08-01)

Hepatitis B virus genotyping among chronic hepatitis B patients with resistance to treatment with lamivudine in the City of Ribeirão Preto, State of São Paulo Genotipagem do vírus da hepatite B de pacientes crônicos com resistência ao tratamento com lamivudina na Cidade de Ribeirão Preto, Estado de São Paulo
by: Rodrigo Haddad, et al.
Published: (2010-06-01)

HBV-INFECTION DE NOVO AFTER ORTHOTOPIC LIVER TRANSPLANTATION: CLINICAL AND VIROLOGICAL CHARACTERISTICS, ASSESSMENT OF ANTIVIRUS THERAPY EFFECTIVENESS
by: O. I. Malomuzh, et al.
Published: (2012-09-01)

Late Hepatitis B reactivation after treatment with rituximab
by: Sara Lacerda Pereira, et al.
Published: (2022-01-01)

Dihydroisoindolo[2,1-a]quinazoline-5,11-dione derivatives as potent and selective inhibitors targeting hepatitis B virus
by: Jun-Fei Zhang, et al.
Published: (2015-07-01)

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa
by: Denise Ilboudo, et al.

LIVER TRANSPLANTATION AND HBV INFECTION
by: O. I. Andreytseva, et al.
Published: (2009-06-01)

Real‐world clinical effectiveness and safety of CT‐P10 in patients with diffuse large B‐cell lymphoma: An observational study in Europe
by: Mark J. Bishton, et al.
Published: (2023-02-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study
by: Yu-Fen Tsai, et al.
Published: (2019-09-01)

HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
by: Xing Cao, et al.
Published: (2021-07-01)

HHV8‐unrelated primary effusion lymphoma in a patient with HBV‐related liver cirrhosis: A case successfully treated with rituximab and lenalidomide
by: Peng‐Jun Liao, et al.
Published: (2023-06-01)

Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma
by: Maria Guarino, et al.
Published: (2017-03-01)

Hepatitis B vaccination in leprosy patients
by: Heitor Rosa, et al.
Published: (1994-09-01)

Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran
by: M Norouzi, et al.
Published: (2012-03-01)

Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran
by: Mehdi Norouzi, et al.
Published: (2010-09-01)

Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa
by: Nokukhanya Msomi, et al.
Published: (2022-04-01)

Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure
by: Romina Salpini, et al.
Published: (2022-09-01)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
by: Azwidowi Lukhwareni, et al.
Published: (2020-06-01)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
by: Lorenzo Piermatteo, et al.
Published: (2021-09-01)

Na<sup>+</sup>-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment
by: Xiaoyu Zhao, et al.
Published: (2021-11-01)

HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma
by: Zijun Ge, et al.
Published: (2019-06-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
by: Aleksandra Urban, et al.
Published: (2022-03-01)

The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus
by: Ankoor Patel, et al.
Published: (2024-01-01)

Incidental hepatitis B virus in Sudanese patients and relative risk factors: Why more screening is needed in primary care?
by: Haifaa A M. Hassan, et al.
Published: (2022-01-01)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

Anti-HBs levels among children and adolescents with complete immunization schedule against hepatitis B virus. A cross-sectional study in Blumenau, State of Santa Catarina, Brazil, 2007-2008 Níveis de anti-HBs entre crianças e adolescentes com o esquema completo de imunização contra o vírus da hepatite B. Um estudo transversal em Blumenau, Estado de Santa Catarina, 2007-2008
by: Andréa do Livramento, et al.
Published: (2011-08-01)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
by: Mariantonietta Pisaturo, et al.
Published: (2019-09-01)

The N-Terminus Makes the Difference: Impact of Genotype-Specific Disparities in the N-Terminal Part of The Hepatitis B Virus Large Surface Protein on Morphogenesis of Viral and Subviral Particles
by: Bingfu Jiang, et al.
Published: (2020-08-01)

Hepatitis B Virus Exploits ERGIC-53 in Conjunction with COPII to Exit Cells
by: Lisa Zeyen, et al.
Published: (2020-08-01)

Hepatitis B Virus Research in South Africa
by: Mohube B. Maepa, et al.
Published: (2022-08-01)

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
by: Giuseppe Gentile, et al.
Published: (2019-11-01)

The association of lncRNA SNPs and SNPs‐environment interactions based on GWAS with HBV‐related HCC risk and progression
by: Qing Liu, et al.
Published: (2021-02-01)